Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $133.0600 (2.33%) ($130.0700 - $133.3900) on Wed. Nov. 22, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.4% (three month average) | RSI | 33 | Latest Price | $133.0600(2.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.7% a day on average for past five trading days. | Weekly Trend | LGND declines -4.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(53%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -0.7% in a week (0% probabilities). TLT(-15%) VIXM(-14%) UUP(-9%) GDXJ(-6%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.7% (StdDev 1.4%) | Hourly BBV | 0 () | Intraday Trend | 2.3% | | | |
|
Resistance Level | $142.04 | 5 Day Moving Average | $135.12(-1.52%) | 10 Day Moving Average | $138.98(-4.26%) | 20 Day Moving Average | $142.04(-6.32%) | To recent high | -9.5% | To recent low | 7.3% | Market Cap | $2.138b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |